As part of the joint stipulation agreement, Padagis is required to report to Arcutis any U.S. Food and Drug Administration correspondence regarding their Abbreviated New Drug Application for their ...

As part of the agreement, Padagis must inform Arcutis of any communication from the U.S. FDA regarding its Abbreviated New Drug Application for a potential generic version of Zoryve cream 0.3% ...